Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 9—September 2009

Research

Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, England

Clarence C. TamComments to Author , Craig D. Higgins, Keith R. Neal, Laura C. Rodrigues, Sally E. Millership, Sarah J. O’Brien, and on behalf of the Campylobacter Case–Control Study Group
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (C.C. Tam, C.D. Higgins, L.C. Rodrigues); University of Nottingham, Nottingham, UK (K.R. Neal); Essex Health Protection Unit, Witham, UK (S.E. Millership); University of Manchester, Manchester, UK (S.J. O’Brien)

Main Article

Table 3

Population–attributable fractions for identified risk factors for Campylobacter enteritis, England, 2005–2006*

Variable PAF, % SE 95% CI
Previous Campylobacter infection 2.6 1.37 0.0–5.3
Proton pump inhibitor use in previous 28 days 10.4 1.70 7.0–13.6
Acquisition of dog in previous month 1.2 1.10 0.0–3.3
Chicken consumption 40.6 11.84 12.2–59.8

*PAF, population–attributable fraction; CI, confidence interval.

Main Article

1The Campylobacter Case–Control Study Group comprises the following: Sarah J. O’Brien (Manchester University); Clarence C. Tam, Craig D. Higgins, Laura C. Rodrigues, and Brendan W. Wren (London School of Hygiene and Tropical Medicine); Keith R. Neal (University of Nottingham); Bob Owen and Judith Richardson (Health Protection Agency Centre for Infections); Bharat C. Patel (Health Protection Agency Collaborating Centre, North Middlesex Hospital); Peter Sheridan (North East and Central London HPU); John Curnow (Cheshire and Merseyside HPU); Ken Lamden (Cumbria and Lancashire HPU); and Sally Millership (Essex HPU).

TOP